An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 208780
Company: LEGACY PHARMA

Products on NDA 208780

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ESBRIET	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	AB	Yes	No
ESBRIET	PIRFENIDONE	534MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET;ORAL	Discontinued	None	Yes	No
ESBRIET	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 208780

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/11/2017	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD; Orphan	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208780s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208780Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208780Orig1s000TOC.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/24/2023	SUPPL-7	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208780s007,022535s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208780Orig1s007;022535Orig1s016ltr.pdf
02/11/2022	SUPPL-5	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022535s015,208780s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/022535Orig1s015; 208780Orig1s005ltr.pdf
07/31/2019	SUPPL-2	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022535s012,208780s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022535Orig1s012, 208780Orig1s002ltr.pdf

Labels for NDA 208780

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/24/2023	SUPPL-7	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208780s007,022535s016lbl.pdf
02/24/2023	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208780s007,022535s016lbl.pdf
02/11/2022	SUPPL-5	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022535s015,208780s005lbl.pdf
07/31/2019	SUPPL-2	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022535s012,208780s002lbl.pdf
01/11/2017	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208780s000lbl.pdf

Therapeutic Equivalents for NDA 208780

ESBRIET

TABLET;ORAL; 267MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ESBRIET	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	Yes	AB	208780	LEGACY PHARMA
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212730	ACCORD HLTHCARE
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212747	AIZANT
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212708	ALEMBIC
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212570	AMNEAL
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212709	APOTEX
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212596	AUROBINDO PHARMA
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212674	HETERO LABS LTD V
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212722	LAURUS
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212680	MICRO LABS
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212772	MSN
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212560	SANDOZ
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212078	SCIEGEN PHARMS
PIRFENIDONE	PIRFENIDONE	267MG	TABLET;ORAL	Prescription	No	AB	212759	TEVA PHARMS USA

TABLET;ORAL; 801MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ESBRIET	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	Yes	AB	208780	LEGACY PHARMA
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212730	ACCORD HLTHCARE
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212747	AIZANT
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212708	ALEMBIC
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212570	AMNEAL
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212709	APOTEX
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212596	AUROBINDO PHARMA
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212674	HETERO LABS LTD V
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212722	LAURUS
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212680	MICRO LABS
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212772	MSN
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212560	SANDOZ
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212078	SCIEGEN PHARMS
PIRFENIDONE	PIRFENIDONE	801MG	TABLET;ORAL	Prescription	No	AB	212759	TEVA PHARMS USA

Top